A Win For Altamira Therapeutics Ltd.

Thu, May 04, 2023 at 07:21 PM

Altamira Therapeutics Ltd. (CYTO:NASDAQ) soared at $1.11, representing a gain of 29.8%. On Thu, May 04, 2023, CYTO:NASDAQ hit a New 2-Week High of $1.11. The stock appeared on our News Catalysts scanner on Mon, May 01, 2023 at 09:25 AM in the 'MISCELLANEOUS' category. From Thu, Apr 20, 2023, the stock recorded 40.00% Up Days and 27.27% Green Days

The stock spiked on Thu, May 04, 2023 at $1.42 with a volume of 32M+.

About Altamira Therapeutics Ltd. (CYTO:NASDAQ)

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders.

Top 10 Gainers:

Soligenix, Inc. (SNGX:NASDAQ), 60.56%
Inseego Corp. (INSG:NASDAQ), 52.66%
SigmaTron International, Inc. (SGMA:NASDAQ), 47.06%
SaverOne 2014 Ltd. (SVRE:NASDAQ), 38.26%
SRAX, Inc. (SRAX:NASDAQ), 37.5%
NANO-X IMAGING LTD (NNOX:NASDAQ), 34.96%
GlucoTrack Inc. (GCTK:NASDAQ), 34.32%
Guardforce AI Co. Limited (GFAI:NASDAQ), 31.63%
Altamira Therapeutics Ltd. (CYTO:NASDAQ), 29.81%
MDJM Ltd. (MDJH:NASDAQ), 28.5%